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The implantable photovoltaic energy harvesting system implanted in the optimal location. 
 
 
Take-Home Messages  
• This is first time to model the performance of implantable PV cells in different layers of tissue. We demonstrate 
how the electrical characteristics are influenced by the implanting location of the device.   
• A PV cell implanted in the dermis layer can harvest the greatest amount of power.  
• We propose implanting our energy harvesting PV cells in the hypodermis layer. 
• Our proposed PV device harvests enough energy to supply power for low-cost implants such as cardiac 
pacemakers, retinal implants or biomedical sensors. 
• PV cells implanted in the adipose layer can harvest nearly 11.84 mW using an 850 nm light source.  
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Photovoltaic Power Harvesting Technologies in 
Biomedical Implantable Devices Considering 
the Optimal Location 
Abstract There are still many challenges in effectively harvesting and generating power for implantable medical devices. Most of 
today’s research focuses on finding ways to harvest energy from the human body to avoid the use of batteries, which require 
surgical replacement. For example, current energy harvesters rely on piezoelectricity, thermoelectricity and solar electricity to 
drive the implantable device. However, the majority of these energy harvesting techniques suffer from a variety of limitations such 
as low power output, large size or poor efficiency. Due to their high efficiency, we focus our attention on solar photovoltaic cells. 
We demonstrate the tissue absorption losses severely influence their performance. We predict the performance of these cells using 
simulation through the verified experimental data. Our results show that our model can obtain 17.20% efficiency and 0.675 V 
open-circuit voltage in one sun condition. In addition, our device can also harvest up to 15 mW/cm2 in dermis and 11.84 mW/cm2 
in hypodermis by using 100 mW/cm2 light source at 800 nm and 850 nm, respectively. We propose implanting our device in 
hypodermis to obtain a stable power output. 
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I. INTRODUCTION1 
iomedical implantable and wearable devices play a 
significant role in modern therapy and 
diagnosis [1]. Due to their clinical demand, a variety of 
subcutaneous devices such as defibrillators, pacemakers, 
cochlear implants, drug pumps, neurological stimulators and 
biomedical sensors are now being developed [2-7]. Power 
harvesting or generation is still a big challenge in these 
devices. Due to the hazardous nature of batteries as well as 
their size, lifespan and the need for surgical replacement, 
alternative energy generation techniques are now in high 
demand [8]. Emerging power harvesters include 
Photovoltaic cells (PV), Piezoelectric Generators (PEG), 
Thermoelectric Cells (TEG), Biofuel Cells (BC), and 
Triboelectric nanogenerators (TENG). They can harvest 
energy from human fluids, the human body or the external 
environment [9-14]. Another alternative method relies on 
Wireless Power Transfer (WPT), which enables power 
transfer between an external power source and an 
implantable device [15, 16]. The literature has demonstrated 
the feasibility of implanting these devices in small 
mammals [8, 17-19], lobsters [20], insects [21, 22] and 
snails [23], with some research based on in-vitro testing [24-
26]. Compared with other power harvesting techniques, 
WPT enables the device to be implanted in the human 
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body [27] and is approved by the Food and Drug 
Administration (FDA) [8, 15]. PEG, TEG and TENG are 
designed to harvest energy produced by body fluids or 
temperature gradients. All of these require specific locations 
with high motion or temperature changes. BC is highly 
biocompatible with living organisms and has been tested 
with plants, insects and mammals [20-23, 28, 29]. Despite its 
low output voltage and enzymatic degradation, the 
abundance of glucose in living organisms makes it a feasible 
power harvesting technology for implantable devices. In 
WPT, the near-field inductive coupling method is mostly 
applied in implantable applications [15]. Large coil size, 
short power range and tissue loss are still unaddressed 
challenges [15, 30].  Ultrasonic power harvesting is one way 
to overcome these drawbacks, but the amount of power is 
lower than 1 mW [31].  
Compared with other technologies, PV cells can produce 
energy in the tens to hundreds of microwatts range within a 
relatively small area (mm2 scale) [26, 32-35]. Previous 
studies have shown that commercial PV cells are capable of 
powering an implantable pacemaker [26]. In L. Lu et al. 
2018 [26], monocrystalline cell arrays were designed and 
tested under a 4 mm skin layer (2 mm pork skin + 2 mm 
chicken muscle). Ultrathin and flexible photovoltaic cells 
were made using biocompatible encapsulation [26]. 
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3 
Moreover, Hung et al. [35] demonstrated that the 
antireflective Silicon Nanowire (SINW) surface produced by 
low-temperature surface passivation can improve the output 
characteristics of CMOS PV cells (Maximum efficiency is 
21.84% (under 5 mW/mm2 condition) and 18.4% (under 
0.5 mW/mm2) without treatment.  Furthermore, the 
performance of these low-cost thin film PV cells can be 
significantly improved using various light trapping 
techniques [35]. Nevertheless, the temperature change from 
15 oC to 45 oC can result in 10% output voltage 
reduction [35]. Similarly, Moon et al. show that an N+P-P+ 
back-side illuminated crystalline silicon cell can harvest low-
flux NIR light in subcutaneous conditions. An efficiency of 
17.12% was achieved using a Si3N4 passivation layer on the 
illuminated surface [36].  
 Tissue loss is still a challenge which limits the harvested 
energy of the PV cells. Maximum transmittance through 
human tissue occurs in the NIR spectral region. Silicon PV 
cells can therefore efficiently accumulate and convert energy 
according to their good response in NIR region [36].  
However, the small incident power according to a small 
active area of implantable PV cell and a high recombination 
rate in NIR region can massively diminish the output 
characteristics [32]. Besides, each person’s skin type (e.g. 
ethnic background, gender and age [37-39]) can affect the 
PV cell’s performance. For toxicity, there are some previous 
works showing feasibility to use silicon PV cells in 
implantable applications. In L. Lu 2018 et al. [26], they 
implemented an ultrathin integrated solar cell array based on 
monocrystalline silicon microcells as a power supply, 
including the active layers, electrodes, interconnections, and 
encapsulation layers using fully biocompatible and 
biodegradable materials. In their study, they designed a 7-
day in-vivo test in a hairless rat. The cytotoxicity test 
provides good biocompatibility of the implantable PV cell. 
The obtained overall viability between 89% and 91% is 
consistent with an absence of any toxic effects. Throughout 
the duration of the experiment, the numbers of dead cells are 
significantly lower than that of the living cells, thereby 
providing evidence of good biocompatibility. 
However, the literature provides little insight into the ideal 
position of implanting these PV cells. There is also no 
mentioning of the optimized device structure, which is 
important before any fabrication and implantation takes 
place. Consequently, we will present our optimized 2D PV 
cell structure using a simulation platform that relies on 
solving Maxwell’s semiconductor equations. In addition, 
light propagation through the stratum corneum, epidermis, 
dermis and adipose will be modelled using the Jones matrix 
technique. Our energy harvesting PV device will be inserted 
in each of these different layers, as shown in Fig. 1. We will 
therefore demonstrate the performance of the PV cell when 
it is placed in different skin locations and skin layers. 
A. Semiconductor principles 
Most PV cells are fabricated using semiconductor 
materials such as Si, GaAs and CdTe. According to the 
literature, organic materials are generating much interest due 
to their flexibility, low price and low fabrication costs. 
However, they still suffer from poor stability and a large 
active area is required due to their low conversion 
efficiency [40]. Most implantable PV cells are made of 
crystalline silicon due to their high efficiency and non-
toxicity [40]. Consequently, we will therefore focus our 
study on semiconductor PV cells. 
 Carrier transport in the semiconductor layers can be 
simulated by invoking the Poisson and continuity equations 
(equations 1a and 1c). Moreover,  we invoke Snell’s law and 
Maxwell’s equations to analyze light penetration using the 
Jones matrix  method [41]. All these equations can be solved 
using the Finite Element Method (FEM) [42]. Thus,  
         (1a) 
          (1b) 
          (1c) 
where n and p are the electron and hole concentrations, ѱ is 
the electrostatic potential, q is the electron charge, ε is the 
permittivity of semiconductor, ND+ and NA- are the ionized 
donor and acceptor impurity concentrations, k is the 
Boltzmann constant, T is the ambient temperature, μn and μp 
are the electron and hole mobilities, Dn,p are the electron and 
hole diffusion coefficient (Dn,p=μn,pkT/q), and G and R 
present the generation rate and recombination rate of 
electron-hole pairs. The recombination rates (R) are 
composed of direct radiative (Rrad), Auger (RAu) and 
Shockley-Read-Hall (RSRH) recombination [42]: 
          (2a) 
       (2b) 
                    (2c) 
where p1,n1 are the trap state hole/electron concentration, geh, 
geeh and gehh are the injection factors, B is the radiative 
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Fig. 1.  The implantable photovoltaic energy harvester, of which structure 
is PPN back-surface illuminated. The device is verified in a multilayer skin 
model by using FEM macroscopic simulation in COMSOL. A, B and C are 
the implant locations in our model: A) under epidermis, B) under dermis, 
and C) under adipose. 
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coefficient, Cn and Cp are the Auger coefficients, τp and τn are 
the recombination lifetimes. The generation rate can be 
determined by [41]: 
             (3) 
where α(λ) is the absorption coefficient of semiconductor, 
b(λ) is the photon flux on the surface, Ps is the power flow 
according to various wavelengths and the depth into the 
device in x- and y- direction. The photon flux can be 
calculated from the light intensity of Air Mass 1.5 Global 
(AM1.5G).  
B. Initial and boundary conditions 
To begin, we apply the neutral charge condition to setup 
the doping profile and ohmic contact characteristics for 
estimating the initial electrostatic potential [41]. In our 
model, we enable periodic boundary conditions to analyze 
carrier diffusion and electrical potentials in the transverse 
directions. The Neumann boundary conditions are applied to 
separate the simulation domains. The fluxes across the 
boundaries were set to zero (ñ·E=0, ñ·Jn,p=0, ñ·Sn,p=0), 
where ñ is the outward-oriented vector.  
C. Performance Characteristics 
The electron current (Jn), hole current (Jp) and short-
circuit current (Jsc) can be determined using [41, 42]: 
                  (4a) 
                  (4b) 
  (4c) 
 Considering the parasitic resistances, the output current 
density of the PV cell can be obtained using [41]: 
       (5) 
where Rs and Rsh are the series and shunt parasitic resistances, 
and VT is the thermal voltage (VT=kq/T). Since our simulation 
model is in 2D, Rs can be neglected and Rsh can be calculated 
using the IV characteristic of the device. The External 
Quantum Efficiency (EQE) can be determined using [41, 
42]: 
                           (6) 
where h is the Plank constant, c is the speed of light, Pin is 
the input power flux density (AM 1.5G light intensity).  
A. Skin Model Description 
 The amount of electrical energy generated from the 
photovoltaic effect in subcutaneous conditions is highly 
related to the thickness and optical properties of skins [43]. 
In this section, we will demonstrate how we can constructed 
a model to simulate light propagation through the skin [26, 
37, 43, 44]. Skin is composed of a number of layers that 
include the Stratum corneum, epidermis, dermis and 
hypodermis (adipose layer). According to K. Song et al. 
2017 [43], the thickness of each of these skin layers is 
inhomogeneous [43] and the  thickness of the epidermis and 
dermis are between 32 µm and 1.8 mm, respectively. In fact, 
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TABLE I 
PARAMETERS USED IN MODEL VERIFICATION AND DEVICE MODELLING  
Global Parameter Value Verified model Value Our model Value 
Χ 4.05 eV [47][51] tn 0.34 µm [32] tn+ 0.25 µm 
Eg 1.124 eV [47] tp 35 µm [32] tp- 49.65 µm 
Nc 2.8×1019 cm-3 [51] Si3N4 100 nm [32] tp+ 0.1 µm 
Nv 1.2×1019 cm-3 [51] n 2.5×1016 cm-3 N+ 1×1019 cm-3 
Dn 36 cm2/s [47] p 2×1017 cm-3 P- 4.6×1015 cm-3 
Dp 12 cm2/s [47] ni 1.0×1010 cm-3 [51] P+ 1×1020 cm-3 
μn 1350 m2/Vs [51] Area 1.23 mm2 ni 1.0×1010 cm-3 [48] 
μp 450 m2/Vs [51] λ 850 nm Area 1 cm2 
Q 1.6022×1019 C [47] I0 1.06 µW/mm2 λ 550 µm 
εr 11.7 [47] T 300 K I0 1000 W/m2 
N(Silicon) [51] τp,n (N layer) 30 µs [52] [53] τp,n (P- layer) 100 µs [52][53] 
K(Silicon) [51] τp,n (P layer) 20 µs [52] [53] τp,n (N+ layer) 80 µs [52] [53] 
Cn 2.8×10-31 cm6s-1 [54]   τp,n (P+ layer) 2 ns [49] [53] 
Cp 9.9×10-32 cm6s-1 [54]   N(stratum corneum) 1.55 [44] 
Brad 1.1×10-14 cm3s-1 [46]   N(epidermis) 1.36 [44] 
C 2.99×108 m/s [47]   N(dermis) 1.41 [44] 
me*/me 1.08 [51]   N(adipose) 1.44 [44] 
mh*/me 0.57 [51]   K(stratum corneum) [44] 
∆ 0.0426 eV [47]   K(epidermis) [44] 
θ 0   K(dermis) [44] 
    K(adipose) [44] 
 This table indicates the parameters used in our device model for verification. 
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5 
the thickness of each layer varies with different skin profiles. 
For example, the stratum corneum is ~10 µm, the epidermis 
is between 100 to 150 µm, the dermis is between 1 to 4 mm, 
and the hypodermis is between 1 mm to 6 mm [44]. 
Consequently, we apply a multi-layer skin structure by using 
a 10 µm stratum corneum, 100 µm epidermis, 1 mm dermis 
and 3 mm hypodermis, which is shown in Fig. 1. The 
propagation of light through the skin can be modelled using 
a 2×2 characteristic matrix [45]: 
 (7) 
where δi is the wave phase shift (δi=2πNidicosθi/λ) in the ith 
layer, Ni is the refractive index, di is the thickness of the ith 
layer, ηi is the pseudo index in ith layer (ηi=Nicosθi). ERa or 
BRa is the ratio between the (electric/magnetic) field of the 
transmitted light and the (electric/magnetic) field of the 
incident light. The reflectance (R), transmittance (T) and 
absorptance (A) of light can be determined using [45]: 
          (8a) 
           (8b) 
                        (8c)  
II. MODEL VERIFICATION 
Before device analysis and optimization, it is imperative 
to verify our model with experimental data. In this case, we 
setup a model of a single junction PV device using the 
parameters shown in Table I. The width and out-of-plane 
thickness of the cell are 1 mm and 1.22 mm respectively. We 
apply the analytical doping method to ensure a uniform 
doping concentration in each layer. The material properties 
are extracted from [46-54]. Comparisons between the 
reference cell [32] and simulations are shown in Figs. 2(a) 
and 2(b), demonstrating a good match between the results. 
The External Quantum Efficiency (EQE) of our model is 
high in both the visible and ultraviolet (UV) regions, due to 
the effective light reflections in both the front and rear 
planes. The JV curve shows a Voc of 0.44 V and a Jsc of 
650 nA/cm2.  
III. RESULTS AND DISCUSSION 
In this section, we demonstrate the performance of our 
device in different skin layers. Initially, we optimized the 
device by changing the doping profile and geometry to 
improve the output performance using the parameters shown 
in Table I. The doping profile changes the band structure of 
the material, and the device performance is limited due to 
recombination losses, which reduces the open circuit voltage 
to less than the theoretical limit [32]. The thickness will 
affect the penetration of light, which will undoubtedly affect 
1
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Fig. 2.  The verified results with our model and [32]. (a) The JV curves of our model and [32] according to different forward bias condition. (b) The EQE value 
comparison between [32] and our model according to different spectra. The value shows great match between our simulation and experimental results in [32]. 
There are slightly difference in visible range and NIR range because the absorption profile of material [32][47] can be different from that in reality according to 
Eq. 3. (c) The efficiency change correlated to doping concentration in different solar cell layers. The results are achieved under one sun condition (100 mW/cm2), 
and thickness of P+ layer, N+ layer and P- layer are 1 μm, 0.25 μm and 50 μm. The optimal doping concentrations of the P+ layer, P- layer and N+ layer is 1×1020 
cm-3, 4.6×1015 cm-3 and 1×1016 cm-3, respectively. (d) The efficiency changes with different layer thickness. The optimal thickness for the P+ layer, N+ layer and 
total device thickness are 0.1 μm, 0.25 μm and 56 μm under one sun condition with doping profile in Table I. 
(a) (b)
(c) (d)
the amount of photo-generated current. In our design, we 
sweep the doping profile of the base layer, front layer and 
back layer, and then check the efficiency changes. Based on 
the inset of Fig. 2 (c), optimal doping concentration for the 
base layer, front layer and back layer are 4.6×1015 cm-3, 
1×1019 cm-3 and 1×1020 cm-3, respectively. For the doping 
concentration in the front layer, we can obtain the same 
efficiency of 16.5% at both 1×1016 cm-3 and 1×1018 cm-3. 
However, we preferred the light doping solution to avoid 
possible defects as a result of excessive doping during 
fabrication. The efficiencies according to the thickness of the 
base layer, front layer and back layer are shown in Fig. 2 (d). 
Based on this, we can obtain the optimal thickness of each 
layer: 50 μm (Base), 0.25 μm (Front) and 0.1 μm (Back).  
 The baseline performance is shown in Fig. 3 under 
AM 1.5G condition (100 mW/cm2). Our device can achieve 
17.20 mW maximum power at 0.585 V with 17.20% 
efficiency. The open-circuit voltage is 0.675 V, and the 
short-circuit current density is 31.42 mA/cm2, which is 
shown in Fig. 3(h) as ‘No skin’. The EQE of our device is 
shown in Fig. 3(g), with a peak value of 75.80% at 750 nm. 
The generation and recombination rates with a 550 nm light 
source are shown in Fig. 3(b), which is obtained using 
equations (3) and (4) without skin. The generation rate 
improves with the depth increased, while there is a trade-off 
point between the generation and recombination rates at a 
depth of 0.23 µm. The electrons are separated and 
accelerated in the junction boundaries, which are shown as 
the peak value in Fig. 3(c).  
  For illustration purposes, we demonstrate the refractive 
index of different skin layers in comparison to silicon PV 
cells, as shown in Fig. 3(d). Obviously, skin has almost one 
third the refractive index of silicon. Similarly, the 
absorptance and transmittance of light through skin are 
shown in Fig. 3(e) and Fig. 3(f), respectively. Overall, since 
light propagations through more tissue, there will be a greater 
amount of attenuation. The epidermis predominantly absorbs 
the light in the UV and visible regions, with 60% of light 
absorbed at 350 nm. The dermis can absorb almost 40% of 
light from all spectra except in the NIR region, where an 
average of 20% is absorbed. The influence of the adipose 
layer is less when compared to the other layers, and a 3 mm 
 
Fig. 3.  (a) The doping profile in our device corresponds to depth. (b) The generation and recombination rate at 550 nm wavelength. (c) The electric field correlated 
to the depth into the PV cell. (d) The refractive index correlated to the depth in the skin model. The Absorptance (e) and Transmittance (f) of the multilayer 
structure with scattering consideration. The structure is composed of 10 µm stratum corneum, 100 µm epidermis, 1 mm dermis and 3 mm adipose (or hypodermis). 
It clearly shows that the transmittance of skin is dramatically degraded with scattering considered. The reflectance is neglected due to its small value (0.1%). 
Besides, it shows that the adipose layer causes less influence in light penetration into the tissue. (g) and (h) show the electric performance of the devices: EQE 
according to spectra, where the peak wavelengths are 750 nm (No skin), 800 nm (A), 832 nm (B without scattering), 850 nm (B) and 850 nm (C).  and JV curves 
of different implanting location according to a wavelength of 550 nm. (i) shows the JV curves when the device is illuminated in peak wavelength obtained from 
Fig. 3(g), 100 mW/cm2 @ 800 nm (A), 832 nm (B without scattering), 850 nm (B) and 850 nm (C). 
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
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adipose can only cause 7% attenuation of light at 550 nm, in 
comparison to 10% loss at 850 nm, respectively. The 
transmittance is inversely proportional to the skin 
absorptance due to the small skin reflectance (less than 3%).  
Fig. 3(g) shows the EQE according to different implant 
layers. When the device is implanted in Test Point A, an EQE 
of 67.50% can be achieved at the peak wavelength of 800 
nm. When implanted in Test Point B, an EQE of 55.60% 
(Scattered) and 43.30% (Non-scattered) can be achieved at 
the peak wavelength of 832 nm and 850 nm, respectively. 
When implanted in Test Point C, the EQE is 38.50% at the 
peak wavelength of 850 nm. Fig. 3(h) shows the JV 
characteristics under 1 Sun illumination conditions (i.e. 
100 mW/cm2 at 550 nm) when the device is implanted in a 
different layer of human tissue as well as without tissue. The 
short circuit current density, Jsc, decreases from 
24.40 mA/cm2 to 8.21 mA/cm2, and the open circuit voltage, 
Voc, decreases from 0.670 V to 0.620 V. Furthermore, the 
maximum power, Pmax, can be determined using the JV 
curves in Figs. 3(h) and 3(i). The power therefore decreases 
from 13.36 ± 1 mW to 4.16 ± 1 mW. The skin transmittance 
influences the light illumination at the device surface, and 
the generation rate will be degraded according to the Eq. 4. 
The Voc is related to the generation rate, which is qualitatively 
consistent with the decrease in Voc (7.46%) [26]. Fig. 3(i) 
shows the JV characteristics at different test point when 
illuminated in the peak wavelength. Light attenuation 
through skin (Between A and C) causes 11 mA/cm2 
difference of Jsc, 0.02 V difference in Voc, and 6.43 mW 
difference in Pmax. The device will generate the highest 
amount of power in point B by illuminating it at the peak 
wavelength, which is 11.84 mW. Considering the power 
output, the dermis layer (between points A and B) is the best 
implant location, since it enables the PV cell to generate 
15 mW for an 800 nm light source and 13 mW for a 550 nm 
source. However, depending upon the type of light source 
and the implantation depth, the amount of harvested power 
will vary. For example, if the device is implanted in the 
narrow region between points A and B, it will generate up to 
8.57 mW for a white light source and 3.45 mW for NIR light. 
This region is typically 1mm in depth. However, if the device 
is implanted between points B and C, which is almost 3 mm, 
it will generate 0.63 mW for a white light source and 
2.98 mW for NIR light. Consequently, we recommend 
implanting our PV cells between regions B and C since it is 
thicker, which makes it easier to implant in the human body 
and the amount of harvested power is constant within this 
region. To overcome the high amount of attenuation, we 
recommend using NIR light. 
Another phenomenon that affects the performance of our 
PV cells is light scattering, which may be due to blood and 
water content in the skin layers. By implanting the device in 
point B, scattering causes a 47% drop in power at 550 nm 
and 9% at 850 nm. Similarly, implanting the device in 
location C results in 28% drop using NIR light and 52% 
using white light. Table II compares our work with 
previously published work [25, 32, 43, 55]. Our proposed 
implantation location (between B and C), illumination 
wavelength (NIR light) and optimised PV cell clearly 
harvests higher power (> 8.35 mW/cm2) than the literature. 
Despite of the comparison between the different PV cells, 
our cell can also compare with the other energy harvesters. 
For output voltage, PV cells are less restricted by the size of 
the organ or the depth of the implants compared with the 
other energy harvesters, which is shown in Figs. 3(h) and 
3(i). In the system level, Some energy harvesters such as 
PEG, TENG and WPT are considered as an AC sources, 
while the implantable PV cell is considered as a DC source, 
relaxing the additional loss due to the extra AC-DC power 
conversion stage [8].  
IV. CONCLUSION 
We have demonstrated the performance of an implantable 
PV device using the FEM method. In our design, PV cells 
implanted in the adipose layer can harvest nearly 11.84 mW 
using an 850 nm light source. This power can drive 
implantable devices such as pacemakers and biomedical 
sensors. The epidermis layer absorbs most of the visible 
light, and the dermis layer absorbs most of the NIR light. We 
further concluded that the dermis layer is a good location for 
implantable PV cell to acquire a high-power output, and the 
adipose layer is an excellent location to obtain a stable power 
output. NIR light enables high skin transmittance and low 
scattering losses, which is beneficial for the PV cell, but may 
be hazardous for the human body due to possible heating 
effects. In future, we will investigate the effect of heat on the 
device performance, as well as the biocompatibility of the 
PV device with the human body.  We will also investigate 
TABLE II 
COMPARISON TABLE WITH THE OTHER WORKS  
Solar cells Illumination Skin type Skin thickness Output Power (a) Reference 
p-i-n Si One Sun Pork 3 mm 0.45 mW/cm2 (b) [25] 
p-n GaAs 134 μW/cm2 LED Rat 4 mm 1.22 mW/cm2 (c) [32] 
p-n Si One Sun Human inner arm 0.951 ± 0.335 mm 3.5 mW/cm2 (d) [43] 
GaAs:GaInP One Sun Rat 675 µm 4.5 mW/cm2 (e) [55] 
n-p-p Si 100 mW/cm2 850nm IR light Human outer arm 4 mm 8.35 mW/cm2  (f) This work 
a Power density can vary according to different experimental conditions. The following indicates the references. 
b Measured by using 3 mm pork skin in-vitro. 
c Measured under 4 mm Rat skin in-vitro, and an LED light source. 
d Measured by using fresh skin from human (Asian 95 years old) in 26 hours after death without embalming process. 
e Measured in vivo using hairless rat. 
f Simulated by using the measured in-vivo human skin properties from literature. The implant location is just under dermis. 
   
 
 
the power transfer between the power harvester and load for 
the in-vitro tests after completing system integration and 
device encapsulation.  
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